Finance

Lists
CTNM:NASDAQ
Contineum Therapeutics Inc
၁၃.၃၈ US$
+၁.၅၂%
(+၀.၂၀) 1D
၁၃.၃၈ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTNM...
Open
၁၃.၁၇ US$
High
၁၃.၈၆ US$
Low
၁၂.၉၄ US$
Mkt. cap
၅၀.၃၄ ကုဋေ
Avg. vol.
၆.၃၅ သိန်း
Volume
၈.၈၆ သိန်း
52-wk high
၁၇.၇၈ US$
52-wk low
၈.၆၀ US$
EPS
-၁.၇၄ US$
Shares outstanding
၃.၃၀ ကုဋေ
No. of employees
၅၁
Open
၁၃.၁၇ US$
High
၁၃.၈၆ US$
Low
၁၂.၉၄ US$
Mkt. cap
၅၀.၃၄ ကုဋေ
Avg. vol.
၆.၃၅ သိန်း
Volume
၈.၈၆ သိန်း
52-wk high
၁၇.၇၈ US$
52-wk low
၈.၆၀ US$
EPS
-၁.၇၄ US$
Shares outstanding
၃.၃၀ ကုဋေ
No. of employees
၅၁
News stories
From web sources and news partners
TradingView
TradingView
·
ပြီးခဲ့သည့် ၁ နာရီ
Key facts: NASDAQ:SPCX to buy 800MHz spectrum; developing non‑GEO D2D
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၀ နာရီ
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
MarketWatch
MarketWatch
·
ပြီးခဲ့သည့် ၂၁ နာရီ
S&P 500 at 10,000 or bust: New ETF offers investors all-or-nothing bet on the index
About Contineum Therapeutics Inc
CEO-
Employees၅၁
Founded၂၀၀၉
Headquarters-
Sector-
Analyst ratings
Based on 8 analysts giving stock ratings to CTNM in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CTNM in the last 3 months.
Highest
Current ၁၃.၃၈ US$
၂၈.၀၀ US$ (+၁၀၉.၂၇%)
Average
၂၂.၂၉ US$ (+၆၆.၅၉%)
Lowest
၁၇.၀၀ US$ (+၂၇.၀၆%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Matteis
Stifel Nicolaus
Buy
Maintained
၂၈.၀၀ US$
+၁၀၉.၃%
09/30/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
၂၆.၀၀ US$
+၉၄.၃%
09/30/2026
Myles Minter
William Blair
Buy
Maintained
-
-
09/30/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
၂၃.၀၀ US$
+၇၁.၉%
09/29/2026
Sean Laaman
Morgan Stanley
Hold
Reiterated
၁၇.၀၀ US$
+၂၇.၁%
09/28/2026
Brian Abrahams
RBC Capital
Buy
Maintained
၂၁.၀၀ US$
+၅၇%
09/21/2026
Unknown Analyst
Leerink Partners
Buy
Maintained
၂၂.၀၀ US$
+၆၄.၄%
09/16/2026
Charles Moore
Robert W. Baird
Buy
Maintained
၁၉.၀၀ US$
+၄၂%
09/15/2026
Last report
၂၀၂၆ ဇူ ၃၀
Fiscal period
Q2 2026
-၀.၄၀ US$ / -၀.၄၅ US$
+၁၀.၈၃%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၀၅ ကုဋေ
၁.၂၀ ကုဋေ
၁.၁၁ ကုဋေ
၁.၂၀ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၄၃ သန်း
၅.၁၂ သန်း
၅.၇၆ သန်း
၅.၄၅ သန်း
Operating expense
၁.၄၉ ကုဋေ
၁.၇၁ ကုဋေ
၁.၆၉ ကုဋေ
၁.၇၄ ကုဋေ
Total operating expenses
၁.၄၉ ကုဋေ
၁.၇၁ ကုဋေ
၁.၆၉ ကုဋေ
၁.၇၄ ကုဋေ
Operating income
-၁.၄၉ ကုဋေ
-၁.၇၁ ကုဋေ
-၁.၆၉ ကုဋေ
-၁.၇၄ ကုဋေ
Other non operating income
၁.၈၃ သိန်း
-၅.၁၀ သောင်း
-၅.၇၀ သောင်း
-၆.၈၀ သောင်း
EBT including unusual items
-၁.၂၈ ကုဋေ
-၁.၅၂ ကုဋေ
-၁.၄၅ ကုဋေ
-၁.၅၂ ကုဋေ
EBT excluding unusual items
-၁.၂၈ ကုဋေ
-၁.၅၂ ကုဋေ
-၁.၄၅ ကုဋေ
-၁.၅၂ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၂၈ ကုဋေ
-၁.၅၂ ကုဋေ
-၁.၄၅ ကုဋေ
-၁.၅၂ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၄၅
-၀.၄၉
-၀.၃၉
-၀.၄၀
Interest and investment income
၁.၉၆ သန်း
၂.၀၁ သန်း
၂.၅၀ သန်း
၂.၃၄ သန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၉၆ သန်း
၂.၀၁ သန်း
၂.၅၀ သန်း
၂.၃၄ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၄၉ ကုဋေ
-၁.၇၀ ကုဋေ
-၁.၆၈ ကုဋေ
-၁.၇၃ ကုဋေ
Gain or loss from assets sale
-
-
၂.၀၀ ထောင်
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ